The program will improve access to adeno-associated virus gene therapy vectors. On Oct. 10, 2023, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results